Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

Share Price is delayed by 15 minutes
Get Live Data
88.00    0.40 (0.46%)
Bid:
87.00
Ask:
89.00
Spread: 2.00 (2.299%)
Market Cap: £92.02m
SDI Live PriceLast checked at - London Stock Exchange

Intraday SDI Group Share Chart

AGM Trading Update

26 Sep 2024 07:00

RNS Number : 6974F
SDI Group PLC
26 September 2024
 

SDI Group plc

("SDI", the "Company", or the "Group")

 

AGM Trading Update

 

26 September 2024 - SDI Group plc, the AIM quoted Group focused on the design and manufacture of products for use in the lab equipment, industrial & scientific sensors and the industrial & scientific products markets, provides an update on trading for the current financial year ("FY25") ahead of today's Annual General Meeting ("AGM").

 

The Company expects to deliver full year results in line with market expectations1. Profit and revenue delivery in FY25 will be weighted more towards H2 than in FY24 due to the current financial year starting slowly, reflecting conditions in certain customer markets. Cash flow has continued to be strong, with unaudited net debt reducing to £11.3m at the end of August 2024 (30 April 2024: £13.2m).

 

SDI remains focused on deploying its dual pronged growth strategy, namely supporting organic growth through initiatives within the portfolio businesses, alongside value-enhancing acquisitions to drive inorganic growth.

 

 

1Analysts from our Broker Cavendish Capital Markets Limited and from Progressive Equity Research regularly provide research on the Company, accessible from our website, and the Group considers the average of their forecasts to represent market expectations for FY25 being Sales of £69.0m and Adjusted Profit Before Tax of £8.35m.

 

 

 

 Enquiries:

 

 

SDI Group plc

Stephen Brown, Chief Executive Officer

Amitabh Sharma, Chief Financial Officer

+44 (0)1223 727144

www.sdigroup.com

 

 

Cavendish Capital Markets Ltd (NOMAD & broker)

Ed Frisby / Seamus Fricker - Corporate Finance

Andrew Burdis / Sunila de Silva - ECM

 

 

+44 (0)20 7220 0500

 

Vigo Consulting (Financial Communications)

Tim McCall / Rozi Morris / Fiona Hetherington

 

+44 (0)20 7390 0230

SDIGroup@vigoconsulting.com 

 

About SDI Group plc:

 

SDl Group plc, specialises in the acquisition and development of companies that design and manufacture products for use in the lab equipment, industrial & scientific sensors and the industrial & scientific products markets. SDI's current portfolio of 14 companies target markets including life sciences, healthcare, astronomy, plastics and packaging, manufacturing, precision optics, measurement instrumentation and art conservation.

 

SDI's growth strategy is twofold: 1) through the enhancement of its portfolio companies (organic growth) and, 2) through the identification and acquisition of complementary, niche technology businesses with established reputations in global markets (inorganic growth).

 

For more information, please see: www.SDIGroup.com

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUVRBRSBUKUAR
Date   Source Headline
12th Dec 20127:00 amRNSUnaudited Interim Results to 31 October 2012
12th Dec 20127:00 amRNSSynoptics Health: ProReveal product launch update
15th Nov 20124:59 pmRNSHolding(s) in Company
16th Oct 20127:00 amRNSIssue of Equity
11th Sep 20123:20 pmRNSResult of AGM
25th Jul 201212:01 pmRNSDirector/PDMR Shareholding
25th Jul 20128:12 amRNSFinal Results
29th May 201210:05 amRNSDirectorate Change
16th Dec 20117:00 amRNSHalf Yearly Report
15th Sep 20111:52 pmRNSAppointment of Acting Managing Director
1st Sep 20112:04 pmRNSResult of AGM
18th Jul 20115:01 pmRNSNotice of Results
1st Jun 20111:00 pmRNSTrading Update
17th Jan 20117:00 amRNSHalf Yearly Report
10th Dec 20103:48 pmRNSTrading Update
27th Sep 201012:01 pmRNSSector Change
23rd Sep 20103:15 pmRNSResult of AGM
19th Jul 20102:27 pmRNSDirector/PDMR Shareholding
19th Jul 20107:00 amRNSFinal Results
16th Jul 20108:58 amRNSAnalyst Presentation
7th Jul 201012:08 pmRNSNotice of Results
7th Jul 201012:01 pmRNSChange of Adviser
28th Jun 20107:00 amRNSSynbiosis Update
24th May 20107:00 amRNSDirectorate Change
21st May 20107:00 amRNSTrading Update
16th Mar 201012:25 pmRNSDirectorate Changes
2nd Mar 20109:59 amRNSTrading Update
10th Feb 20107:00 amRNSNew Atik Camera
25th Jan 20107:00 amRNSHalf Yearly Report
4th Jan 20104:20 pmRNSDirectorate Change
9th Dec 20091:46 pmRNS12 Months on AIM
21st Oct 200911:21 amRNSResult of AGM
16th Oct 20093:45 pmRNSIssue of Equity
14th Oct 20094:50 pmRNSChange of Adviser
14th Sep 20097:00 amRNSFinal Results
18th Jun 20094:52 pmRNSExercise of Options
7th Apr 20097:00 amRNSTrading Statement
6th Feb 20094:14 pmRNSDirector/PDMR Shareholding
27th Jan 20097:30 amRNSInterim Results
8th Dec 20087:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.